I 
114TH CONGRESS 
2D SESSION 
H. R. 5645 
To authorize the Secretary of Health and Human Services to award grants 
for Alzheimer’s disease research. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 6, 2016 
Mr. ISRAEL introduced the following bill; which was referred to the Committee 
on Energy and Commerce 
A BILL 
To authorize the Secretary of Health and Human Services 
to award grants for Alzheimer’s disease research. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘United States-Israel 
Alzheimer’s Disease Cooperation Act’’. 
SEC. 2. FINDINGS. 
The Congress finds the following: 
(1) It is in the highest national interests of the 
United States to further research into Alzheimer’s 
disease. 
VerDate Sep 11 2014 
00:26 Jul 08, 2016
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5645.IH
H5645
SSpencer on DSK4SPTVN1PROD with BILLS
(2) The State of Israel is a steadfast ally of the 
United States. 
(3) The special relationship between the United 
States and Israel is manifested in a variety of coop-
erative scientific research and development pro-
grams, such as— 
(A) the United States-Israel Binational 
Science Foundation; 
(B) the United States-Israel Binational In-
dustrial Research and Development Founda-
tion; and 
(C) the United States-Israel Energy Co-
operation Act. 
(4) Those programs have made possible many 
scientific, technological, and commercial break-
throughs in fields including the life sciences, medi-
cine, bioengineering, agriculture, biotechnology, com-
munications, and energy development. 
(5) Israeli scientists are at the forefront of re-
search and development in the field of Alzheimer’s 
disease. 
(6) Enhanced cooperation between the United 
States and Israel for the purpose of research in Alz-
heimer’s disease would be in the national interests of 
both countries. 
VerDate Sep 11 2014 
00:26 Jul 08, 2016
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5645.IH
H5645
SSpencer on DSK4SPTVN1PROD with BILLS
SEC. 3. GRANTS FOR ALZHEIMER’S DISEASE RESEARCH. 
(a) GRANT PROGRAM.— 
(1) ESTABLISHMENT.—The Secretary of Health 
and Human Services (in this section referred to as 
the ‘‘Secretary’’) shall establish a program of award-
ing grants to support research on the development 
and commercialization of applicable tools, treat-
ments, and cures for Alzheimer’s disease and other 
dementias. 
(2) ELIGIBLE
PROJECTS.—To be eligible for 
funding under this section, a project shall— 
(A) be designed to further research de-
scribed in paragraph (1); and 
(B) be a joint venture between— 
(i)(I) a for-profit business entity, aca-
demic institution, National Laboratory (as 
defined in section 2 of the Energy Policy 
Act of 2005 (42 U.S.C. 15801)), or non-
profit entity in the United States; and 
(II) a for-profit business entity, aca-
demic institution, or nonprofit entity in 
Israel; or 
(ii)(I) the Federal Government; and 
(II) the Government of Israel. 
(3) APPLICATIONS.—To seek a grant under this 
section, an applicant shall submit to the Secretary 
VerDate Sep 11 2014 
00:26 Jul 08, 2016
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5645.IH
H5645
SSpencer on DSK4SPTVN1PROD with BILLS
an application in accordance with procedures estab-
lished by the Secretary, in consultation with the ad-
visory board established under paragraph (4). 
(4) ADVISORY BOARD.— 
(A) 
ESTABLISHMENT.—The 
Secretary 
shall establish an advisory board— 
(i) to monitor the method by which 
grants are awarded under this section; and 
(ii) to provide to the Secretary peri-
odic performance reviews of actions taken 
to carry out this section. 
(B) COMPOSITION.—The advisory board 
established under subparagraph (A) shall be 
composed of 3 members, to be appointed by the 
Secretary, of whom— 
(i) 1 shall be a representative of the 
Federal Government; 
(ii) 1 shall be selected from a list of 
nominees provided by the United States- 
Israel Binational Science Foundation; and 
(iii) 1 shall be selected from a list of 
nominees provided by the United States- 
Israel Binational Industrial Research and 
Development Foundation. 
VerDate Sep 11 2014 
00:26 Jul 08, 2016
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5645.IH
H5645
SSpencer on DSK4SPTVN1PROD with BILLS
(5) CONTRIBUTED
FUNDS.—Notwithstanding 
section 3302 of title 31, United States Code, the 
Secretary may accept, retain, and use funds contrib-
uted by any person, government entity, or organiza-
tion for purposes of carrying out this section— 
(A) without further appropriation; and 
(B) without fiscal year limitation. 
(6) REPORT.—Not later than 180 days after 
the date of completion of a project for which a grant 
is provided under this section, the grant recipient 
shall submit to the Secretary a report that con-
tains— 
(A) a description of the method by which 
the recipient used the grant funds; and 
(B) an evaluation of the level of success of 
each project funded by the grant. 
(7) CLASSIFICATION.—Grants shall be awarded 
under this section only for projects that are consid-
ered to be unclassified by both the United States 
and Israel. 
(b) TERMINATION.—The grant program and the ad-
visory committee established under this section terminate 
on the date that is 7 years after the date of enactment 
of this Act. 
VerDate Sep 11 2014 
00:26 Jul 08, 2016
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5645.IH
H5645
SSpencer on DSK4SPTVN1PROD with BILLS
(c) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$3,000,000 for the period of fiscal years 2017 through 
2023. Any amounts appropriated pursuant to this sub-
section shall be in addition to amounts accepted, retained, 
and used pursuant to subsection (a)(5). 
Æ 
VerDate Sep 11 2014 
00:26 Jul 08, 2016
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H5645.IH
H5645
SSpencer on DSK4SPTVN1PROD with BILLS